New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture
- PMID: 18312167
- DOI: 10.1517/14656566.9.4.663
New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture
Comment on
-
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312. N Engl J Med. 2007. PMID: 17476007 Clinical Trial.
-
Zoledronic acid and clinical fractures and mortality after hip fracture.N Engl J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941. Epub 2007 Sep 17. N Engl J Med. 2007. PMID: 17878149 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources